当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.Management for Progress
2.Inclusion Criteria

Patients who replies "No" to any of the above questions will not enter the study

3. Ages between 18~65 years old

Date

yyyy-mm-dd

Doctor's signature

1. Patients with either II-degree debrided burn wound or donor site

3.Exclusion Criteria

Patients who replies "Yes" to any of the above questions will not enter the study

Doctor's signature

Date

yyyy-mm-dd

2.Baseline
1.Management for Progress
2.General Information

Other diseases

If yes, please describe

History of allergic disease

If yes, please describe

If yes, please describe

If yes, please describe

Date

yyyy-mm-dd

Doctor's signature

Name of Drug

Date of birth

yyyy-mm-dd

Education level

Start Date

Systolic pressure (SP)

mmHg

End Date

Diastolic pressure (DP)

mmHg

Dosage per Day

Respiratory rate

次/分

Grouping

Route of Administration

Pulse rate

次/分

Marital status

3.Physical Examination

Wound Bed (erythema)

Signs and Symptoms

Wound Location

Wound Surface Area

cm2

Wound Bed (bleeding)

Wound Bed (exudation)

Wound Type

4.Lab Investigations

Uric acid

μmol/L

Creatinine

μmol/L

Urea nitrogen

mmol/L

Serum albumin

g/L

Serum bilirubin

μmol/L

AST

U/L

ALT

U/L

Urine protein

g/L (或定性)

Urine red cell

个/μL (或定性)

Urine WBC

个/μL (或定性)

PLT

X10*9/L

Hb

g/L

RBC

X10^12/L

WBC

X10*9/L

Routine Urinalysis

Routine Blood Test

Date of test

Date of examination

yyyy-mm-dd

Liver Function Test

Date of test

yyyy-mm-dd

Renal Function Test

Date of test

yyyy-mm-dd

3.In the process of the treatment
1.Treatment Record
4.At the end of the treatment
1.Management for Progress
5.SOPs
1.Treatment SOP
6.Research team
1.Institutions
7.Design, Methods
1.Calculations of sample size